Select neurocognitive impairment in HIV-infected women: Associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere length

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Giesbrecht, Chantelle J ^a,b   Thornton, Allen E ^a,b   Hall Patch, Clare ^c,d   Maan, Evelyn J ^c,d   Côté, Hélène C F ^d,e,f   Money, Deborah M ^c,d,e,f   Murray, Melanie ^c,d,e,f   Pick, Neora ^c,d,e,f  

^a SIMON FRASER UNIVERSITY   (Canada)

^b British Columbia Mental Health and Addictions Research Institute   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^d CIHR Emerging Team in HIV Therapy and Aging (CARMA)   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f WOMEN S HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; APTITUDE TEST; ARTICLE; ATTENTION; BRAIN FUNCTION; CAMBRIDGE NEUROPSYCHOLOGICAL TEST AUTOMATED BATTERY; CELL AGING; COGNITION; COGNITIVE DEFECT; COMORBIDITY; COMPOSITE COGNITIVE INDEX; CONTROLLED STUDY; CORRELATION ANALYSIS; DECISION MAKING; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; EDUCATION; ETHNICITY; EXECUTIVE FUNCTION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; INFORMATION PROCESSING; LEARNING; LEUKOCYTE; LEUKOCYTE TELOMERE LENGTH; MAJOR CLINICAL STUDY; MIXED INFECTION; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PREDICTION; PSYCHOMETRY; SELF REPORT; TELOMERE HOMEOSTASIS; VIRUS DETECTION; VIRUS LOAD; WORKING MEMORY; COMPLICATION; HEPACIVIRUS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; STANDARD; TELOMERE; VIROLOGY;

ADULT; COGNITION DISORDERS; DEMOGRAPHY; DEPRESSION; FEMALE; HEPACIVIRUS; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; LEUKOCYTES; MIDDLE AGED; REFERENCE STANDARDS; TELOMERE; VIRAL LOAD;

EID: 84897097442     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089556     Document Type: Article

References (110)

1. Patel S, Kolson D, Glosser G, Matozzo I, Ge Y, et al. (2002) Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients. Am J Neuroradiol 23: 543-549. (Pubitemid 34411906)
2. Paul R, Cohen R, Navia B, Tashima K (2002) Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1. Neurosci Biobehav Rev 26: 353-359. 10.1016/S0149-7634(02)00006-4. (Pubitemid 34553318)
3. Anthony I, Ramage S, Carnie F, Simmonds P, Bell J (2005) Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 64: 529-536. (Pubitemid 40781156)
4. Thompson P, Dutton R, Hayashi K, Toga A, Lopez O, et al. (2005) Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4(+) T lymphocyte decline. Proc Natl Acad Sci U S A 102: 15647-15652. 10.1073/pnas.0502548102. (Pubitemid 41528110)
5. Chang L, Andres M, Sadino J, Jiang CS, Nakama H, et al. (2011) Impact of apolipoprotein E epsilon 4 and HIV on cognition and brain atrophy: Antagonistic pleiotropy and premature brain aging. Neuroimage 58: 1017-1027. 10.1016/j.neuroimage.2011.07.010.
6. Ances BM, Ortega M, Vaida F, Heaps J, Paul R (2012) Independent effects of HIV, aging, and HAART on brain volumetric measures. J Acquir Immune Defic Syndr 59: 469-477. 10.1097/QAI.0b013e318249db17.
7. Becker JT, Maruca V, Kingsley LA, Sanders JM, Alger JR, et al. (2012) Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology 54: 113-121. 10.1007/s00234-011-0854-2.
8. Towgood KJ, Pitkanen M, Kulasegaram R, Fradera A, Kumar A, et al. (2012) Mapping the brain in younger and older asymptomatic HIV-1 men: Frontal volume changes in the absence of other cortical or diffusion tensor abnormalities. Cortex 48: 230-241. 10.1016/j.cortex.2011.03.006.
9. Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER study. Neurology 75: 2087-2096. 10.1212/WNL.0b013e318200d727.
10. Simioni S, Cavassini M, Annoni J, Abraham AR, Bourquin I, et al. (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24: 1243-1250. 10.1097/QAD.0b013e3283354a7b.
11. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, et al. (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. J Neurovirol 17: 3-16. 10.1007/s13365-010-0006-1.
12. Al-Khindi T, Zakzanis KK, van Gorp WG (2011) Does antiretroviral therapy improve HIV-associated cognitive impairment? A quantitative review of the literature. JINS 17: 956-969. 10.1017/S1355617711000968.
13. Dawes S, Suarez P, Casey CY, Cherner M, Marcotte TD, et al. (2008) Variable patterns of neuropsychological performance in HIV-1 infection. J Clin Exp Neuropsychol 30: 613-626. 10.1080/13803390701565225. (Pubitemid 351957691)
14. Hart RP, Wade JB, Klinger RL, Levenson JL (1990) Slowed information-processing as an early cognitive change associated with aids and arc. J Clin Exp Neuropsychol 12: 72-72.
15. Llorente AM, Miller EN, D'Elia LF, Selnes OA, Wesch J, et al. (1998) Slowed information processing in HIV-1 disease. J Clin Exp Neuropsychol 20: 60-72. (Pubitemid 28318059)
16. Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore DJ, et al. (2004) Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol 18: 234-248. (Pubitemid 39180728)
17. Chang L, Ernst T, Witt MD, Ames N, Gaiefsky M, et al. (2002) Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. Neuroimage 17: 1638-1648. 10.1006/nimg.2002.1254. (Pubitemid 35333882)
18. Judd F, Komiti A, Chua P, Mijch A, Hoy J, et al. (2005) Nature of depression in patients with HIV/AIDS. Aust N Z J Psychiatry 39: 826-832. 10.1080/j.1440-1614.2005.01659.x. (Pubitemid 43904477)
19. Peavy G, Jacobs D, Salmon DP, Butters N, Delis DC, et al. (1994) Verbal memory performance of patients with human-immunodeficiency-virus infection - evidence of subcortical dysfunction. J Clin Exp Neuropsychol 16: 508-523. 10.1080/01688639408402662. (Pubitemid 24228963)
20. Woods SP, Scott JC, Dawson MS, Morgan EE, Carey CL, et al. (2005) Construct validity of hopkins verbal learning test - revised component process measures in an HIV-1 sample. Arch Clin Neuropsychol 20: 1061-1071. 10.1016/j.acn.2005.06.007. (Pubitemid 41642942)
21. Carey CL, Woods SL, Rippeth JD, Heaton RK, Grant I, et al. (2006) Prospective memory in HIV-1 infection. J Clin Exp Neuropsychol 28: 536-548. 10.1080/13803390590949494.
22. Martin EM, Nixon H, Pitrak DL, Weddington W, Rains NA, et al. (2007) Characteristics of prospective memory deficits in HIV-seropositive substance-dependent individuals: Preliminary observations. J Clin Exp Neuropsychol 29: 496-504. 10.1080/13803390600800970. (Pubitemid 46918934)
23. Maki PM, Cohen MH, Weber K, Little DM, Fornelli D, et al. (2009) Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women. Neurology 72: 1661-1668. 10.1212/WNL.0b013e3181a55f65.
24. Hinkin CH, Hardy DJ, Mason KI, Catellon SA, Lam MN, et al. (2002) Verbal and spatial working memory performance among HIV-infected adults. JINS 8: 532-538. 10.1007/S1355617701020276. (Pubitemid 34578318)
25. Martin E, Pitrak D, Weddington W, Rains N, Nunnally G, et al. (2004) Cognitive impulsivity and HIV serostatus in substance dependent males. JINS 10: 931-938. 10.1017/S1355617704107054.
26. Hardy D, Hinkin C, Levine A, Castellon S, Lam M (2006) Risky decision making assessed with the gambling task in adults with HIV. Neuropsychology 20: 355-360. 10.1037/0894-4105.20.3.355. (Pubitemid 43886870)
27. Iudicello JE, Woods SP, Parsons TD, Moran LM, Carey CL, et al. (2007) Verbal fluency in HIV infection: A meta-analytic review. JINS 13: 183-189. 10.1017/S1355617707070221. (Pubitemid 46487390)
28. Iudicello JE, Woods SP, Weber E, Dawson MS, Scott JC, et al. (2008) Cognitive mechanisms of switching in HIV-associated category fluency deficits. J Clin Exp Neuropsychol 30: 797-804. 10.1080/13803390701779578.
29. Munoz-Moreno JA, Fumaz CR, Ferrer MJ, Prats A, Negredo E, et al. (2008) Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. AIDS Res Hum Retroviruses 24: 1301-1307. 10.1089/aid.2007.0310.
30. Cattie JE, Doyle K, Weber E, Grant I, Woods SP, et al. (2012) Planning deficits in HIV-associated neurocognitive disorders: Component processes, cognitive correlates, and implications for everyday functioning. J Clin Exp Neuropsychol 34: 906-918. 10.1080/13803395.2012.692772.
31. Stern RA, Arruda JE, Somerville JA, Cohen RA, Boland RJ, et al. (1998) Neurobehavioral functioning in asymptomatic HIV-1 infected women. JINS 4: 172-178. (Pubitemid 28156092)
32. Levine AJ, Hinkin CH, Miller EN, Becker JT, Selnes OA, et al. (2007) The generalizability of neurocognitive test/retest data derived from a nonclinical sample for detecting change among two HIV+ cohorts. J Clin Exp Neuropsychol 29: 669-678. 10.1080/13803390600920471. (Pubitemid 47254602)
33. Manly JJ, Smith C, Crystal HA, Richardson J, Golub ET, et al. (2011) Relationship of ethnicity, age, education, and reading level to speed and executive function among HIV+ and HIV-women: The women's interagency HIV study (WIHS) neurocognitive substudy. J Clin Exp Neuropsychol 33: 853-863. 10.1080/13803395.2010.547662.
34. Lopez O, Wess J, Sanchez J, Dew M, Becker J (1999) Neurological characteristics of HIV-infected men and women seeking primary medical care. Eur J Neurol 6: 205-209. 10.1111/j.1468-1331.1999.tb00014.x. (Pubitemid 29141902)
35. Gatali M, Archibald C (2004) Women and HIV. BMC Womens Health 4 Suppl 1:S27.
36. Maki PM, Martin-Thormeyer E (2009) HIV, cognition and women. Neuropsychol Rev 19: 204-214.
37. Logie CH, James L, Tharao W, Loutfy MR (2011) HIV, gender, race, sexual orientation, and sex work: A qualitative study of intersectional stigma experienced by HIV-positive women in Ontario, Canada. PLoS Med 8: e1001124. 10.1371/journal.pmed.1001124.
38. Wang X, Salters KA, Zhang W, McCandless L, Money D, et al. (2012) Women's health care utilization among harder-to-reach HIV-infected women ever on antiretroviral therapy in British Columbia. AIDS Res Treat 560361.doi: 10.1155/2012/560361.Epub 2012 Nov 26.
39. Carter AJ, Min JE, Chau W, Lima VD, Pick N, et al. (2013) Gender inequities in 'quality of initial HIV care' (QOC) among HIV-positive individuals initiating antiretroviral treatment in British Columbia, Canada (2000-2010). Can J Infect Dis Med Microbiol 24: p19A.
40. Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, et al. (2011) CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS 25: 1747-1751. 10.1097/QAD.0-b013e32834a40cd.
41. Tozzi V, Balestra P, Galgani S, Narciso P, Ferri F, et al. (1999) Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS 13: 1889-1897. 10.1097/00002030-199910010-00011. (Pubitemid 29509548)
42. Devlin KN, Gongvatana A, Clark US, Chasman JD, Westbrook ML, et al. (2012) Neurocognitive effects of HIV, hepatitis C, and substance use history. JINS 18: 68-78. 10.1017/S1355617711001408.
43. Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, et al. (2003) Computerized reaction time battery versus a traditional neuropsychological battery: Detecting HIV-related impairments. JINS 9: 64-71. 10.1017/ S1355617703910071. (Pubitemid 36150139)
44. Paul R, Flanigan TP, Tashima K, Cohen R, Lawrence J, et al. (2005) Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus. J Neuropsychiatry Clin Neurosci 17: 114-118. 10.1176/appi.neuropsych.17.1.114. (Pubitemid 40283778)
45. Vitiello B, Goodkin K, Ashtana D, Shapshak P, Atkinson JH, et al. (2007) HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people. AIDS 21: 1415-1422. 10.1097/QAD.0b013e328220e71a. (Pubitemid 46988001)
46. Ettenhofer ML, Hinkin CH, Castellon SA, Durvasula R, Ullman J, et al. (2009) Aging, neurocognition, and medication adherence in HIV infection. Am J Geriatr Psychiatry 17: 281-290.
47. Shimizu SM, Chow DC, Valcour V, Masaki K, Nakamoto B, et al. (2011) The impact of depressive symptoms on neuropsychological performance tests in HIV-infected individuals: A study of the hawaii aging with HIV cohort. World J AIDS 1:139-145.
48. Clifford DB, Evans SR, Yang YJ, Gulick RM (2005) The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. AIDS 19: S64-S71. 10.1097/01.aids.0000192072.80572.43. (Pubitemid 41682171)
49. Richardson JL, Nowicki M, Danley K, Martin EM, Cohen MH, et al. (2005) Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women. AIDS 19: 1659-1667. (Pubitemid 41502679)
50. Hinkin CH, Castellon SA, Levine AJ, Barclay TR, Singer EJ (2008) Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis 27: 11-17. 10.1300/J069v27n02-02.
51. Durvasula RS, Miller EN, Myers HF, Wyatt GE (2001) Predictors of neuropsychological performance in HIV positive women. J Clin Exp Neuropsychol 23: 149-163. (Pubitemid 32511317)
52. Margolin A, Avants SK, Warburton LA, Hawkins KA (2002) Factors affecting cognitive functioning in a sample of human immunodeficiency virus-positive injection drug users. AIDS Patient Care STDS 16: 255-267. (Pubitemid 34620334)
53. Durvasula RS, Myers HF, Mason K, Hinkin C (2006) Relationship between alcohol use/abuse, HIV infection and neuropsychological performance in African American men. J Clin Exp Neuropsychol 28: 383-404. 10.1080/13803390590935408.
54. Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, et al. (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53: 1120-1126. 10.1093/cid/cir627.
55. Pathai S, Lawn SD, Gilbert CE, McGuinness D, McGlynn L, et al. (2013) Accelerated biological ageing in HIV-infected individuals in South Africa: A case-control study. AIDS 27: 2375-2384.
56. Malan-Mueller S, Hemmings SMJ, Spies G, Kidd M, Fennema-Notestine C, et al. (2013) Shorter telomere length - A potential susceptibility factor for HIV-associated neurocognitive impairments in South African woman. PLoS One 8: e58351. 10.1371/journal.pone.0058351.
57. Zanet D L., Sattha B, Maan E, Thorne A, Gadawski I, et al. (2012) Factors associated with shorter leukocyte telomere length in HIV+ and HIV- adults. Can J Infect Dis Med Microbiol 23 (Suppl A): Oral Presentation 0008.
58. Effros R, Allsopp R, Chiu C, Hausner M, Hirji K, et al. (1996) Shortened telomeres in the expanded CD282 CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 10: F17-F22. 10.1097/00002030-199607000-00001. (Pubitemid 26229506)
59. Palmer L, Weng N, Levine B, June C, Lane H, et al. (1997) Telomere length, telomerase activity, and replicative potential in HIV infection: Analysis of CD4(+) and CD8(+) T cells from HIV-discordant monozygotic twins. J Exp Med 185: 1381-1386. 10.1084/jem.185.7.1381. (Pubitemid 27172918)
60. Pommier J, Gauthier L, Livartowski J, Galanaud P, Boue F, et al. (1997) Immunosenescence in HIV pathogenesis. Virology 231: 148-154. 10.1006/viro.1997.8512. (Pubitemid 27238773)
61. Rickabaugh TM, Kilpatrick RD, Hultin LE, Hultin PM, Hausner MA, et al. (2011) The dual impact of HIV-1 infection and aging on naive CD4(+) T-cells: Additive and distinct patterns of impairment. PLoS One 6: e16459. 10.1371/journal.pone.0016459.
62. Hearps AC, Maisa A, Cheng W, Angelovich TA, Lichtfuss GF, et al. (2012) HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS 26: 843-853. 10.1097/QAD.0b013e328351f756.
63. Cote HCF, Soudeyns H, Thorne A, Alimenti A, Lamarre V, et al. (2012) Leukocyte telomere length in HIV-infected and HIV-exposed uninfected children: Shorter telomeres with uncontrolled HIV viremia. PLoS One 7: e39266. 10.1371/journal.pone.0039266.
64. von Zglinicki T, Serra V, Lorenz M, Saretzki G, Lenzen-Grossimlighaus R, et al. (2000) Short telomeres in patients with vascular dementia: An indicator of low antioxidative capacity and a possible risk factor? Lab Invest 80: 1739-1747. 10.1038/labinvest.3780184.
65. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, et al. (2003) Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 24: 77-84. 10.1016/S0197-4580(02)00043-X. (Pubitemid 35454145)
66. Honig LS, Schupf N, Lee JH, Tang MX, Mayeux R (2006) Shorter telomeres are associated with mortality in those with APOE epsilon 4 and dementia. Ann Neurol 60: 181-187. 10.1002/ana.20894. (Pubitemid 44182393)
67. Martin-Ruiz C, Dickinson HO, Keys B, Rowan E, Kenny RA, et al. (2006) Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol 60: 174-180. 10.1002/ana.20869. (Pubitemid 44182392)
68. Valdes AM, Deary IJ, Gardner JP, Kimura M, Lu X, et al. (2008) Leukocyte telomere length is associated with cognitive performance in healthy women. Neurobiol Aging : 1-7.
69. Yaffe K, Lindquist K, Kluse M, Cawthon R, Harris T, et al. (2011) Telomere length and cognitive function in community-dwelling elders: Findings from the health ABC study. Neurobiol Aging 32: 2055-2060. 10.1016/j. neurobiolaging.2009.12.006.
70. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799. 10.1212/01.WNL.0000287431.88658.8b. (Pubitemid 350059308)
71. Burgess P, Alderman N, Evans J, Emslie H, Wilson B (1998) The ecological validity of tests of executive function. JINS 4: 547-558. (Pubitemid 29043460)
72. Bell-McGinty S, Podell K, Franzen M, Baird A, Williams M (2002) Standard measures of executive function in predicting instrumental activities of daily living in older adults. Int J Geriatr Psychiatry 17: 828-834. 10.1002/gps.646.
73. Cahn-Weiner D, Boyle PA, Malloy PF (2002) Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Appl Neuropsychol 9: 187-191. 10.1207/S15324826AN0903-8. (Pubitemid 36134212)
74. Zanet DL, Saberi S, Oliveira L, Sattha B, Gadawski I, et al. (2013) Blood and dried blood spot telomere length measurement by qPCR: Assay considerations. PLoS One 8: e57787. 10.1371/journal.pone.0057787.
75. Radloff LS (1977) The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, Appl Psychol Meas 1: 385-401.
76. The Psychological Corporation (2001) Wechsler test of adult reading. San Antonio, TX: Harcourt Assessment.
77. Fray P, Robbins T, Sahakian B (1996) Neuropsychiatric applications of CANTAB. Int J Geriatr Psychiatry 11: 329-336.
78. Ruff R, Parker S (1993) Gender-specific and age-specific changes in motor speed and eye-hand coordination in adults - normative values for the finger tapping and grooved pegboard tests. Percept Mot Skills 76: 1219-1230.
79. Brandt J, Benedict RHB (2001) Hopkins verbal learning test - revised: Professional manual. Lutz, FL: Psychological Assessment Resources Inc.
80. Wechsler D (2008) WAIS-IV administration and scoring manual (Canadian). San Antonio, TX: The Psychological Corporation.
81. Robbins TW, James M, Owen AM, Sahakian BJ, Lawrence AD, et al. (1998) A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: Implications for theories of executive functioning and cognitive aging. JINS 4: 474-490. (Pubitemid 28461619)
82. Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, et al. (2000) The unity and diversity of executive functions and their contributions to complex "frontal lobe" tasks: A latent variable analysis. Cogn Psychol 41: 49-100. 10.1006/cogp.1999.0734.
83. Testa R, Bennett P, Ponsford J (2012) Factor analysis of nineteen executive function tests in a healthy adult population. Arch Clin Neuropsychol 27: 213-224. 10.1093/arclin/acr112.
84. Richardson JL, Martin EM, Jimenez N, Danley K, Cohen M, et al. (2002) Neuropsychological functioning in a cohort of HIV infected women: Importance of antiretroviral therapy. JINS 8: 781-793.
85. Hestad KA, Menon JA, Silalukey-Ngoma M, Franklin DR, Jr., Imasiku ML, et al. (2012) Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection A pilot study in Zambia, Africa. J Nerv Ment Dis 200: 336-342. 10.1097/NMD.0b013e31824cc225.
86. Cohen J (1992) A power primer. Psychol Bull 112: 155-159. 10.1037/0033-2909.112.1.155.
87. Hedges L, Olkin I (1984) Nonparametric estimators of effect size in meta-analysis. Psychol Bull 96: 573-580. 10.1037//0033-2909.96.3.573.
88. Cohen J, Cohen P, West SG, Aiken LS (2003) Categorical or nominal independent variables. In: D. . Riegert, editor. Applied multiple regression/correlation analysis for the behavioral sciences (3rd ed.). Mahwah, NJ: Lawrence Erlbaum Associates, Inc. pp. 302-353.
89. Benowitz N (1993) Clinical-pharmacology and toxicology of cocaine. Pharmacol Toxicol 72: 3-12.
90. Meyer JS, Quenzer LF (2005) Psychomotor stimulants: Cocaine and the amphetamines. In: JS . Meyer, LF . Quenzer, editors. Psychopharmacology: Drugs, the brain, and behavior. Sunderland, MA: Sinauer Associates, Inc. pp. 276-300.
91. Spronk DB, van Wel JHP, Ramaekers JG, Verkes RJ (2013) Characterizing the cognitive effects of cocaine: A comprehensive review. Neurosci Biobehav Rev 37: 1838-1859.
92. Potter GG, McQuoid DR, Payne ME, Taylor WD, Steffens DC (2012) Association of attentional shift and reversal learning to functional deficits in geriatric depression. Int J Geriatr Psychiatry 27: 1172-1179. 10.1002/gps.3764.
93. Tabachnick B, Fidell L (2007) Using multivariate statistics. Boston, MA: Pearson. 980 p.
94. Gibbie T, Mijch A, Ellen S, Hoy J, Hutchison C, et al. (2006) Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Med 7: 112-121. 10.1111/j.1468-1293.2006.00350.x.
95. Fray PJ, Robbins TW (1996) CANTAB battery: Proposed utility in neurotoxicology. Neurotoxicol Teratol 18: 499-504. (Pubitemid 26288719)
96. Stuss D, Levine B (2002) Adult clinical neuropsychology: Lessons from studies of the frontal lobes. Annu Rev Psychol 53: 401-433. 10.1146/annurev. psych.53.100901.135220.
97. Fellows L, Farah M (2003) Ventromedial frontal cortex mediates affective shifting in humans: Evidence from a reversal learning paradigm. Brain 126: 1830-1837. 10.1093/brain/awg180. (Pubitemid 36917342)
98. Hornak J, O'Doherty J, Bramham J, Rolls E, Morris R, et al. (2004) Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans. J Cogn Neurosci 16: 463-478. 10.1162/089892904322926791. (Pubitemid 38392404)
99. Hampshire A, Owen AM (2006) Fractionating attentional control using event-related fMRI. Cereb Cortex 16: 1679-1689. 10.1093/cercor/bhj116. (Pubitemid 44729906)
100. Van der Molen MJW, Van der Molen MW, Ridderinkhof KR, Hamel BCJ, Curfs LMG, et al. (2012) Attentional set-shifting in fragile X syndrome. Brain Cogn 78: 206-217. 10.1016/j.bandc.2011.12.008.
101. Leeson VC, Robbins TW, Matheson E, Hutton SB, Ron MA, et al. (2009) Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: Stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry 66: 586-593. 10.1016/j.biopsych.2009.05.016.
102. Faílde-Garrido JM, Rodríguez Alvarez M, Simón-López MA (2008) Neuropsychological impairment and gender differences in HIV-1 infection. Psychiatry Clin Neurosci 62: 494-502. 10.1111/j.1440-1819.2008.01841.x.
103. Mather KA, Jorm AF, Parslow RA, Christensen H (2011) Is telomere length a biomarker of aging? A review. J Gerontol A Biol Sci Med Sci 66: 202-213. 10.1093/gerona/glq180.
104. Cherkas LF, Hunkin JL, Kato BS, Richards JB, Gardner JP, et al. (2008) The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med 168: 154-158. 10.1001/archinternmed.2007.39. (Pubitemid 351185881)
105. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, et al. (1999) Estrogen activates telomerase. Cancer Res 59: 5917-5921. (Pubitemid 30004951)
106. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, et al. (2008) Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65: 65-70. 10.1001/archneurol.2007.31.
107. Clark L, Cools R, Robbins T (2004) The neuropsychology of ventral prefrontal cortex: Decision-making and reversal learning. Brain Cogn 55: 41-53. 10.1016/s0278-2626(03)00284-7. (Pubitemid 38591429)
108. Owsley C, Sloane M, McGwin G, Ball K (2002) Timed instrumental activities of daily living tasks: Relationship to cognitive function and everyday performance assessments in older adults. Gerontology 48: 254-265. 10.1159/000058360. (Pubitemid 34621625)
109. Vigil O, Posada C, Woods SP, Atkinson H, Heaton RK, et al. (2008) Impairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infection. J Clin Exp Neuropsychol 30: 805-815. 10.1080/13803390701802354.
110. Ettenhofer ML, Foley J, Castellon SA, Hinkin CH (2010) Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology 74: 1217-1222.